Alcon Operating Margin 2019-2024 | ALC
Alcon Operating Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM Operating Income | Operating Margin |
2024-12-31 | $9.91B | $1.41B | 14.26% |
2024-09-30 | $9.76B | $1.23B | 12.56% |
2024-06-30 | $9.64B | $1.19B | 12.32% |
2024-03-31 | $9.56B | $1.14B | 11.91% |
2023-12-31 | $9.46B | $1.04B | 10.99% |
2023-09-30 | $9.27B | $0.85B | 9.19% |
2023-06-30 | $9.09B | $0.76B | 8.41% |
2023-03-31 | $8.88B | $0.69B | 7.82% |
2022-12-31 | $8.72B | $0.67B | 7.71% |
2022-09-30 | $8.70B | $0.83B | 9.58% |
2022-06-30 | $8.66B | $0.65B | 7.49% |
2022-03-31 | $8.55B | $0.68B | 7.92% |
2021-12-31 | $8.29B | $0.58B | 7.00% |
2021-09-30 | $8.08B | $0.54B | 6.67% |
2021-06-30 | $7.82B | $0.39B | 4.99% |
2021-03-31 | $6.92B | $-0.31B | -4.41% |
2020-12-31 | $6.83B | $-0.48B | -7.05% |
2020-09-30 | $6.81B | $-0.69B | -10.15% |
2020-06-30 | $6.84B | $-0.58B | -8.48% |
2020-03-31 | $7.53B | $-0.17B | -2.22% |
2019-12-31 | $7.51B | $-0.19B | -2.49% |
2019-06-30 | $5.49B | $-0.39B | -7.01% |
2019-03-31 | $5.41B | $-0.29B | -5.44% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | MED INSTRUMENTS | $48.486B | $9.911B |
Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. |